Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The procedure described by CPT® Code 89254 involves the identification of oocytes, or eggs, from follicular fluid. This process begins with the collection of follicular aspirates, which are obtained through a separate, reportable procedure. Once collected, the aspirates are placed into a test tube for further examination. The contents of this test tube are then distributed into a very thin layer across several Petri dishes, allowing for optimal visibility and examination. Each Petri dish is scrutinized under a stereo dissecting microscope, which is equipped with an illuminated base and a heated stage to facilitate the identification of oocytes. During this examination, the presence of oocytes is confirmed, and the maturation stage of each oocyte is assessed. Additionally, the condition of the surrounding coronal and cumulus cells is evaluated, as these factors are crucial in determining the viability and maturity of the oocytes. Notably, the presence of a single polar body is a key indicator of oocyte maturity. The identification process continues until all oocytes have been thoroughly examined, isolated, and documented, ensuring a comprehensive assessment of the follicular fluid's contents.
© Copyright 2026 Coding Ahead. All rights reserved.
The procedure associated with CPT® Code 89254 is indicated for the identification of oocytes from follicular fluid, which is essential in various reproductive health assessments. The following conditions may warrant this procedure:
The procedure for oocyte identification from follicular fluid involves several detailed steps to ensure accurate assessment and documentation of the oocytes present. The following steps outline the process:
After the oocyte identification procedure is completed, the findings are typically documented in a report that may be used for further clinical decision-making. Patients may be advised on the next steps in their fertility treatment plan based on the results of the oocyte assessment. Additionally, any necessary follow-up procedures or treatments may be discussed with the patient, depending on the outcomes of the oocyte examination. It is important for healthcare providers to ensure that patients understand the implications of the findings and the potential options available for their reproductive health.
| Short Descr | OOCYTE IDENTIFICATION | Medium Descr | OOCYTE ID FROM FOLLICULAR FLU | Long Descr | Oocyte identification from follicular fluid | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | STV-Packaged Codes | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 1 | CCS Clinical Classification | 206 - Microscopic examination (bacterial smear, culture, toxicology) |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 1998-01-01 | Added | First appearance in code book in 1998. |
Get instant expert-level medical coding assistance.